Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

1.

Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective.

Lachaine J, Beauchemin C, Sasane R, Hodgkins PS.

Postgrad Med. 2012 May;124(3):139-48. doi: 10.3810/pgm.2012.05.2557.

PMID:
22691908
[PubMed - indexed for MEDLINE]
2.

Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.

Christensen L, Sasané R, Hodgkins P, Harley C, Tetali S.

Curr Med Res Opin. 2010 Apr;26(4):977-89. doi: 10.1185/03007991003673617.

PMID:
20178404
[PubMed - indexed for MEDLINE]
3.

Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program.

Lawson KA, Johnsrud M, Hodgkins P, Sasané R, Crismon ML.

Clin Ther. 2012 Apr;34(4):944-956.e4. doi: 10.1016/j.clinthera.2012.02.021. Epub 2012 Mar 22.

PMID:
22444786
[PubMed - indexed for MEDLINE]
4.

ADHD medication use, adherence, persistence and cost among Texas Medicaid children.

Barner JC, Khoza S, Oladapo A.

Curr Med Res Opin. 2011;27 Suppl 2:13-22. doi: 10.1185/03007995.2011.603303.

PMID:
21973228
[PubMed - indexed for MEDLINE]
5.

A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.

Faraone SV, Glatt SJ.

J Clin Psychiatry. 2010 Jun;71(6):754-63. doi: 10.4088/JCP.08m04902pur. Epub 2009 Dec 29.

PMID:
20051220
[PubMed - indexed for MEDLINE]
6.

Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations.

Molife C, Bernauer MJ, Farr AM, Haynes VS, Kelsey D.

Postgrad Med. 2012 Sep;124(5):7-22. doi: 10.3810/pgm.2012.09.2586.

PMID:
23095422
[PubMed - indexed for MEDLINE]
7.

Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.

Winterstein AG, Gerhard T, Shuster J, Zito J, Johnson M, Liu H, Saidi A.

Ann Pharmacother. 2008 Jan;42(1):24-31. Epub 2007 Nov 27.

PMID:
18042808
[PubMed - indexed for MEDLINE]
8.

Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.

Wong IC, Asherson P, Bilbow A, Clifford S, Coghill D, DeSoysa R, Hollis C, McCarthy S, Murray M, Planner C, Potts L, Sayal K, Taylor E.

Health Technol Assess. 2009 Oct;13(50):iii-iv, ix-xi, 1-120. doi: 10.3310/hta13490.

PMID:
19883527
[PubMed - indexed for MEDLINE]
Free Article
9.

Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge.

Huang YS, Tsai MH.

CNS Drugs. 2011 Jul;25(7):539-54. doi: 10.2165/11589380-000000000-00000. Review. Erratum in: CNS Drugs. 2011 Nov 1;25(11):932. Dosage error in article text.

PMID:
21699268
[PubMed - indexed for MEDLINE]
10.

Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder.

Palli SR, Kamble PS, Chen H, Aparasu RR.

J Child Adolesc Psychopharmacol. 2012 Apr;22(2):139-48. doi: 10.1089/cap.2011.0028. Epub 2012 Feb 24.

PMID:
22364400
[PubMed - indexed for MEDLINE]
11.

Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population.

Hodgkins P, Sasané R, Christensen L, Harley C, Liu F.

Curr Med Res Opin. 2011;27 Suppl 2:53-62. doi: 10.1185/03007995.2011.623158.

PMID:
21973231
[PubMed - indexed for MEDLINE]
12.

Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents.

Sikirica V, Haim Erder M, Xie J, Macaulay D, Diener M, Hodgkins P, Wu EQ.

Pharmacoeconomics. 2012 Aug 1;30(8):e1-15. doi: 10.2165/11632920-000000000-00000.

PMID:
22788263
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008.

Kornfield R, Watson S, Higashi AS, Conti RM, Dusetzina SB, Garfield CF, Dorsey ER, Huskamp HA, Alexander GC.

Psychiatr Serv. 2013 Apr 1;64(4):339-46. doi: 10.1176/appi.ps.201200147.

PMID:
23318985
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Indication and use of drug products used to treat attention-deficit/hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in adulthood.

Brinker A, Mosholder A, Schech SD, Burgess M, Avigan M.

J Child Adolesc Psychopharmacol. 2007 Jun;17(3):328-33.

PMID:
17630866
[PubMed - indexed for MEDLINE]
15.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
[PubMed - indexed for MEDLINE]
16.

Factors associated with initiation with atomoxetine versus stimulants in the treatment of adults with ADHD: retrospective analysis of administrative claims data.

Van Brunt DL, Johnston JA, Ye W, Pohl GM, O'Hara NN.

J Manag Care Pharm. 2006 Apr;12(3):230-8.

PMID:
16623607
[PubMed - indexed for MEDLINE]
Free Article
17.

Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder.

Kaplan G, Newcorn JH.

Pediatr Clin North Am. 2011 Feb;58(1):99-120, xi. doi: 10.1016/j.pcl.2010.10.009. Review.

PMID:
21281851
[PubMed - indexed for MEDLINE]
18.

Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications.

Setyawan J, Guérin A, Hodgkins P, Gauthier G, Cloutier M, Wu E, Erder MH.

J Med Econ. 2013 Nov;16(11):1275-89. doi: 10.3111/13696998.2013.839947. Epub 2013 Sep 19.

PMID:
24004347
[PubMed - indexed for MEDLINE]
19.

Mechanism of action of agents used in attention-deficit/hyperactivity disorder.

Wilens TE.

J Clin Psychiatry. 2006;67 Suppl 8:32-8. Review.

PMID:
16961428
[PubMed - indexed for MEDLINE]
20.

Pharmacotherapy of attention-deficit hyperactivity disorder in adolescents.

Childress AC, Berry SA.

Drugs. 2012 Feb 12;72(3):309-25. doi: 10.2165/11599580-000000000-00000. Review.

PMID:
22316347
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk